key: cord-0955387-u2tznejy
authors: Cavalcante, Marcelo Borges; de Melo Bezerra Cavalcante, Candice Torres; Sarno, Manoel; Barini, Ricardo; Kwak-Kim, Joanne
title: Maternal immune responses and obstetrical outcomes of pregnant women with COVID-19 and possible health risks of offspring
date: 2020-11-19
journal: J Reprod Immunol
DOI: 10.1016/j.jri.2020.103250
sha: c2d25229f7ea0acbcfeefd263fb018ea81fada10
doc_id: 955387
cord_uid: u2tznejy

Coronavirus disease 2019 (COVID-19) pandemic has spread rapidly across the world. The vast majority of patients with COVID-19 manifest mild to moderate symptoms but may progress to severe cases or even mortalities. Young adults of reproductive age are the most affected population by SARS-CoV-2 infection. However, there is no consensus yet if pregnancy contributes to the severity of COVID-19. Initial studies of pregnant women have found that COVID-19 significantly increases the risk of preterm birth, intrauterine growth restriction, and low birth weight, which have been associated with non-communicable diseases in offspring. Besides, maternal viral infections with or without vertical transmission have been allied with neurological and behavioral disorders of the offspring. In this review, obstetrical outcomes of women with COVID-19 and possible risks for their offspring are discussed by reviewing maternal immune responses to COVID-19 based on the current evidence. Structural and systemic follow-up of offspring who are exposed to SARS-CoV-2 in-utero is suggested.

1 hypertension, preeclampsia (PE), eclampsia, and hemolysis, elevated liver enzyme, low platelet (HELLP) syndrome (Wu et al. 2020b) . The impact of COVID-19 on the health of pregnant women is still poorly understood. Initial studies failed to deliver a clear picture of defining pregnancy as a risk factor for the severity of COVID-19, unlike other pulmonary viral infections, such as H1N1 infection (Malinowski et al. 2011 , Knight et al. 2020 . Few studies have evaluated the prevalence of COVID-19 in pregnant women. The study from a maternity hospital in New York, NY, US, reported a 15.4% prevalence of SARS-CoV-2 infection in pregnant women admitted for delivery, including 1.9% symptomatic and 13.5% asymptomatic cases (Sutton et al. 2020) . Another study reported a 12.2% prevalence of SARS-CoV-2 infection among pregnant women without specifying each trimester (Fox and Melka 2020) . With the emerging SARS-CoV-2 antibody testing, 6.2% (80/1,293) of parturient women in Philadelphia, PA, US (from April 4 to June 3, 2020) was reported to have IgG and/or IgM SARS-CoV-2-specific antibodies (Flannery et al. 2020) .

Initial studies have shown that COVID-19 increases the risk of preterm birth (PTB), low birth weight (LBW), and the need for neonatal hospitalization in a neonatal intensive care unit (NICU) (Juan et al. 2020 , Smith et al. 2020 . However, the literature has not yet clearly defined the risks for pregnancy loss (miscarriage and stillbirth), PE, and the vertical transmission of the disease in pregnant women with COVID-19 (Dashraath et al. 2020 , Karimi-Zarchi et al. 2020 , Mendoza et al. 2020 , Smith et al. 2020 . Although, in a small series of pregnant women with severe COVID-19, a PE-like syndrome, a variant clinical manifestation of PE, has been reported (Mendoza et al. 2020) . During pregnancy, several viral infections have been known to increase the risk of fetal malformations, PTB, and intrauterine growth restriction (IUGR) without a significant long-term impact on the offspring's health (Racicot and Mor 2017) . Recent experimental models 1 in animals and epidemiological studies in humans, however, have shown that offspring exposed to maternal viral infection in-utero or born with LBW are at high risk for chronic non-communicable diseases (NCDs) and psychiatric disorders (Smith et al. 2007 , Choi et al. 2016 , He et al. 2017 , Al Salmi and Hannawi 2020 . Therefore, we aim to review the maternal immune responses and obstetrical outcomes in pregnant women with COVID-19 and discuss the potential impact on the offspring's health, particularly the long-term health concerns, based on the current data in the literature.

SARS-CoV-2 infects human beings through angiotensin-converting enzyme 2 (ACE2) receptor, which is highly expressed in the alveolar epithelium and also present in various cells at the maternal-fetal junction and fetal tissues (Eguchi et al. 2018) . Briefly, the SARS-CoV-2 spike protein binds to the ACE2 receptor, leading to the down-regulation of these receptors with excessive production of the vasoconstrictor angiotensin II (AngII) and reduction of the vasodilator angiotensin-(1-7) [Ang-(1-7)]. Increased AngII interacts with the angiotensin-1 receptor (AT1R) and activates the downstream nuclear factor kappa B pathway. Consequently, it increases the production of IL-6, TNF-α, IL-1ß and IL-10, and pulmonary vascular permeability. At the same time, the low concentration of Ang-(1-7) contributes to the loss of its modulatory effect via Mas receptor (MasR) that attenuates inflammatory response (Eguchi et al. 2018 , Murakami et al. 2019 , Jing et al. 2020 . Studies have shown that inflammatory cytokines, chemokines, and factors in the peripheral blood, such as interleukin (IL)-2, IL-6, IL-7, granulocyte colony-stimulating factor (G-CSF), macrophage inflammatory protein (MIP) 1-α, tumor necrosis factor-α (TNF-α), C-reactive 1 protein (CRP), ferritin, and D-dimer are significantly elevated in the patients with the severe form of COVID-19 (Feng et al. 2020 , Siddiqi and Mehra 2020 , Wu et al. 2020a ).

SARS-CoV-2 infection is known to induce a decrease in CD4 + and CD8 + T and natural killer (NK) cell levels, more evidently in critically ill patients. Despite decreased T cells, the immune response of COVID-19 is characterized by the increased Th17 response, with a concurrent reduction of regulatory T (Treg)/Th17 cell ratios. Studies have suggested that the uncontrolled release of pro-inflammatory cytokines in COVID-19 cases is due to the exaggerated Th17 response (Muyayalo et al. 2020 , Xu et al. 2020 ). Yet, the immune mechanisms of cytokine storm syndrome (CSS) in COVID-19 are not fully understood. Interestingly, it has also been described in several severe acute respiratory syndromes, such as middle east respiratory syndrome (MERS), severe acute respiratory syndrome (SARS), and seasonal influenza (H5N1 and H1N1). The cytokine profiles described in the CSS of each respiratory syndromes were similar, suggesting common pathophysiology; SARS [IFN-γ, IL-1, IL-6, IL-12, TGF-β, monocyte chemoattractant protein (MCP)-1, monokine induced by gamma (MIG), IFN-γ inducible protein (IP)-10, IL-8], MERS [IFN-α, IL-1β, IL-2, IL-6, IL-8, MCP-1, MIP-1a, CCL-5], H1N1 Influenza (IFN-γ, TNF-α, IL-6, IL-8, IL-9, IL-17, IL-15, IL-12p70), and H1N5 influenza (IFN-γ, IL-6, IL-8, IL-10, MCP-1, MIG, IP-10) (Gao et al. 2020) . A recent study of the inflammatory cytokine profiles in three different groups of patients with respiratory infections, including hospitalized-but-stable COVID-19 patients, COVID-19 patients requiring intensive care unit (ICU) admission, and patients with severe community-acquired pneumonia requiring ICU support, revealed that the inflammatory cytokines, including IL-1β, IL-6, IL-8, and soluble TNF receptor 1 (sTNFR1) were significantly elevated in COVID-19 cases when compared to patients who required ICU support without COVID-19 (McElvaney et al. 2020) . This finding was consistent with a recent meta-analysis, J o u r n a l P r e -p r o o f demonstrating the elevation of several inflammatory markers, such as procalcitonin, CRP, and IL-6, in patients with COVID-19 (Feng et al. 2020) , and another study which described changes in inflammatory markers, such as IL-6, IL-1β, IL-10, TNF, GM-CSF, IP-10, IL-17, MCP-3, and IL-1ra in COVID-19 patients (Wang et al. 2020 , Wu et al. 2020a .

The expression of ACE2 in the female reproductive tract and placental tissue suggests that SARS-CoV-2 infection may compromise pregnancy outcomes and vertically transmit to a fetus (Jing et al. 2020) . Indeed, electron microscope and molecular biology studies have identified the presence of SARS-CoV-2 in the placental villous stroma and membranes of infected mothers (Algarroba et al. 2020 , Penfield et al. 2020 . Hence, intrauterine fetuses in mothers with SARS-Cov-2 infection can be exposed to pro-inflammatory milieu either directly induced by fetal or placental tissue or indirectly by maternal immune responses. In COVID-19 cases, shifted Th17 immunity has been reported to induce pro-inflammatory cytokine excess (Muyayalo et al. 2020 , Xu et al. 2020 . Notably, the balanced Treg/Th17 immune responses are critical for embryonic implantation and healthy pregnancy (Figueiredo and Schumacher 2016, Jørgensen et al. 2019) , while reduced levels of Treg cells and increased levels of Th17 cells are associated with obstetric complications, such as miscarriage, preeclampsia, and PTB (Zenclussen et al. 2005 , Sasaki et al. 2007 , Lee et al. 2012 , Jabalie et al. 2019 , Krechetova et al. 2020 . Therefore, it is speculated that pro-inflammatory immune responses to SARS-CoV-2 by maternal and fetal immune effectors and trophoblasts may increase maternal risks for obstetrical complications and possibly offspring risk for short-and long-term NCD.

Pro-inflammatory immune responses are dominant during implantation and parturition in normal pregnancy, systemically and locally , Liu et al. 2020 . The proinflammatory immune response of pregnant women with COVID-19 appears to be similar to that of non-pregnant women. However, the risk of adverse clinical outcomes in pregnant women with COVID-19 is still unclear. Some authors have observed that pregnant women with COVID-19 had a clinical course of the disease similar to that of non-pregnant women. In contrast, others suggest that the pregnant status raises the morbidity of COVID-19, especially in the presence of risk factors such as black and Hispanic race, obesity, advanced maternal, age, and medical comorbidities (Brandt et al. 2020) .

Mortality in pregnant women with COVID-19 appears to be similar to that observed among pregnant women without COVID-19 and the general population. The COVID-19 related maternal mortality ratio (MMR) in 194 obstetric units in the UK was 1% (5/427 pregnant women) and in 33 French maternity units was 0.2% (1/617 pregnant women) (Kayem et al. 2020 , Knight et al. 2020 ). An epidemiological study of reproductive age women with COVID-19, performed in the period January 22-June 7, 2020, in the US, revealed that pregnant women have the same MR as non-pregnant women [16/8,207 (0.2%) versus 208/83,205 (0.2%), adjusted Relative Risk (aRR) 0.9, 95% confidence interval (CI) 0.5-1.5]. However, pregnant women with COVID-19 were more likely to be admitted to the intensive care unit (ICU) (aRR 1.5, 95% CI 1.2-1.8) and receive mechanical ventilation (aRR 1.7, 95% CI 1.2-2.4) (Ellington et al. 2020) . Contrarily, Takemoto et al. reported a significantly higher MMR among Brazilian pregnant women with COVID-19 (12.7%) than that of the general population (overall 5%) (Takemoto et al. 2020) . women were more likely to show evidence of MVM with villous agglutination and subchorionic thrombus than those from SARS-CoV-2 negative women. Interestingly, the frequency of these histopathological findings was not different between symptomatic and asymptomatic COVID-19

cases (Smithgall et al. 2020) . Therefore, the placental pathology seems to progress regardless of maternal clinical manifestation, and even asymptomatic pregnant women with COVID-19 may have an increased risk of developing obstetrical complications.

The placental abnormalities, such as MVM, observed in the cases of pregnant women with COVID-19 have been associated with IUGR (Wong et al. 2004 , Ng et al. 2006 , Levytska et al. 2017 ). Previously, the presence of intense infiltration of macrophages in the placenta and elevated levels of placental inflammatory markers have been reported to be associated with a reduction in fetal growth rate (Sharps et al. 2020 COVID-19, including asymptomatic cases, should be considered.

The impact of COVID-19 on pregnancy outcomes is still poorly understood. Studies in pregnant women during previous outbreaks of other coronaviruses (SARS and MERS) have observed an increased risk for miscarriage, PTB, and IUGR (Wong et al. 2004 , Dashraath et al. 2020 ). The occurrence of other flu-like syndromes during pregnancy, such as H1N1 influenza, is also associated with an elevated risk of PTB (RR 3.9, 95% CI: 2.7-5.6) and LBW (RR 4.6, 95%

CI: 2.9-7.5 ) (Meijer et al. 2015 , Newsome et al. 2019 . The initial pregnancy outcomes reports of pregnant women infected with COVID-19 suggest an increase in the risk of PTB and LBW (Huntley et al. 2020 , Smith et al. 2020 , particularly in the latter half of the pregnancy (≥ 20 weeks gestation) (Badr et al. 2020 ). (Trocado et al. 2020) . Other studies have not found a higher rate of PTB among pregnant women with COVID-19 (Zhang et al. 2020 ).

Prematurity could be spontaneous or induced in pregnant women with COVID-19, and the severity of COVID-19 may be a factor inducing PTB. Unfortunately, the majority of the studies did not report the nature of PTB precisely. It should also be noted that there are undoubtedly differences in practice between countries that influence the results. In general, these data suggest a trend that maternal COVID-19 increases the risk for PTB and LBW.

The PTB has been a global concern for maternal health, neonatal mortality, and morbidity.

Recently, particular attention has been given to repercussions throughout the lives of preterm babies. The global prevalence of PTB was estimated to be 10.6% (Chawanpaiboon et al. 2019 ).

The PTB rates in China and the US are 7.3% and 10%, respectively (Chen et al. 2019 , Martin et al. 2019 . When compared to the overall prevalence of PTB in different countries, the first report of the obstetrical outcomes of pregnant women with COVID-19 revealed a significant increase in the PTB (Capobianco et al. 2020 , Huntley et al. 2020 , Knight et al. 2020 , Smith et al. 2020 .

Consequently, these newborns have short-, medium-, and long-term health risks. In the neonatal period and the first months of life, the main complications of premature babies are respiratory distress, retinopathy of prematurity, patent ductus arteriosus, bronchopulmonary dysplasia, metabolism disorders, late-onset sepsis, necrotizing enterocolitis, intraventricular hemorrhage, and periventricular leukomalacia (Stoll et al. 2010) . Premature birth may lead to the following longterm complications, including cerebral palsy, impairment of lung function, impaired learning, J o u r n a l P r e -p r o o f vision and hearing abnormalities, dental disorders, behavioral and psychological problems, growth impairment, and chronic adult diseases, namely insulin resistance, chronic kidney disease (CKD), and hypertension (Holsti et al. 2017 , Kuint et al. 2017 ). Figure 1 narrates the possible COVID-19related long-term offspring risks.

WHO defines LBW as a birth weight less than 2,500g (up to and including 2,499g), The overall prevalence of LBW is estimated to be between 15-20%, ranging from 6% in East Asia and the Pacific, 13% in Sub-Saharan Africa, and up to 28% in South Asia (Cutland et al. 2017 , Kanda et al. 2020 . LBW is associated with high neonatal mortality (>20 times greater than neonates with a birth weight of >2.5Kg), long-term neurologic disability, impaired language development, impaired academic achievement, and increased risk of chronic NCDs in offspring, such as obesity, CKD, cardiovascular disease (CVD) and diabetes mellitus (DM) (Silverwood et al. 2013 , Cutland et al. 2017 , Al Salmi and Hannawi 2020 , Kanda et al. 2020 . Since the Baker's initial study on the fetal origin of diseases in adulthood, fetal exposure to adverse conditions during pregnancy is considered as a risk factor for NCDs (The fetal origin of the adult disease -Barker's Hypothesis). There are likely two main mechanisms involved. The first one is that immature organ development may be induced by adverse conditions during pregnancy, such as infections and J o u r n a l P r e -p r o o f placental pathologies, which leads to structural changes and impaired functioning of the affected organ, for example, reduced islet cell mass and β cell numbers, reduction in the number of functional nephrons. The second mechanism is epigenetic modification (Barker et al. 2009 there is no data to support the increased risk of NCD later in the life of COVID-19 affected children, and the vertical transmission of SARS-CoV-2 seems to happen rarely. Hence, it remains as a hypothetical question.

The association between viral infection and pregnancy loss has been debated for decades.

Some viral infections increase the risk of miscarriage and stillbirth. The mechanisms that induce pregnancy loss are still poorly understood (Racicot and Mor, 2017) . Giakoumelou et al. suggested that the direct viral action or maternal immunological changes, which induce trophoblastic and placental lesions, are involved in the pathophysiology of pregnancy loss (Giakoumelou et al. 2016 ). The ideal maternal immune response for a successful pregnancy depends on a balance

between T-helper 1 (Th1) and T-helper-2 (Th2) immunity. Therefore, from an immunological point of view, hypothetically, the severe form of COVID-19 may increase the risk of pregnancy losses (Liu et al. 2020) . women during the COVID-19 pandemic. Therefore, it is necessary to carry out studies that assess the impact of COVID-19 on the risk of pregnancy loss.

Since the beginning of the COVID-19 pandemic, researchers have investigated the possibility of SARS-CoV-2 vertical transmission and the consequential impact on fetuses. To date, there is no observational study to assess the impact of maternal infection by other coronaviruses on the behavioral and neurological health of offspring. However, there is strong evidence that different viral infections, such as severe acute respiratory syndrome by influenza H1N1 virus in pregnant women, can compromise the offspring's health even when the infection is limited to the mother or placental bed without fetal infection (Brown et al. 2004 , Canetta et al. 2014b , He et al. 2020 , Song et al. 2020 . Animal and epidemiological studies suggested that viral infections in pregnant women, which did not cross the placenta, were also associated with neurological and behavioral diseases in offspring (Knuesel et al. 2014 , Al-Haddad et al. 2019 ).

Maternal immune responses to SARS-CoV-2 have similarities to those reported in women with flu-like syndrome, hence, raising concern for possible neurological and behavioral disorders in the offspring of pregnant women with COVID-19. In a recent meta-analysis including 7,865 COVID-19 patients, a significant decrease in lymphocytes, including CD4 + T cells, CD8 + T cells, CD3 + cells, CD19 + B cells, NK cells, and monocytes, and an increase in the white blood cell, neutrophils, neutrophil to lymphocyte ratio, CRP, erythrocyte sedimentation rate (ESR), ferritin, procalcitonin (PCT), serum amyloid A (SAA), IL-2, IL-2R, IL-4, IL-6, IL-8, IL-10, TNF-α, and IFN-γ were present in the severe cases compared to those of non-severe cases. However, there are no significant differences in IL-1β, IL-17, and CD4/CD8 T cell ratio between these groups (Akbari et al. 2020) . These changes were similar to those of H1N1 influenza. 

Observational studies demonstrate the correlation between viral infections in pregnancy and a higher prevalence of schizophrenia and other psychotic disorders in offspring. The higher maternal levels of IgG and IgM before the delivery of affected offspring with schizophrenia and other psychotic disorders were reported compared with those of controls (Buka et al. 2001) .

Besides, for the first time, the occurrence of influenza during the first half of pregnancy was reported to increases the risk of schizophrenia spectrum disorders (SSD) (OR 3.00, 95% CI 0.9-10.1, p=0.05) (Brown et al. 2004) . Additionally, influenza infection during pregnancy seems to increase the risk for offspring to develop bipolar disorder with psychotic features (OR 5.03, 95% CI 1.38-10.1, p=0.05) (Canetta et al. 2014b) . Maternal exposure to herpes simplex virus 2 is also associated with an increased risk for psychoses among adult offspring (OR 2.6, 95% CI 1.4-4.6) (Buka et al. 2008) . Recent studies suggest that the placental inflammatory process induces changes in local gene expression, increasing the risk of behavioral diseases, such as schizophrenia (Knuesel et al. 2014 , Ursini et al. 2018 , Al-Haddad et al. 2019 . Changes in the secretion of placental neurotransmitters such as serotonin, changes in dopaminergic and GABAergic activity in the fetal brain, and the diverged development of cholinergic neurons in the fetal basal forebrain induced by maternal inflammation are other possible mechanisms that increase the risk of neurological and behavioral disorders in offspring of pregnant women with viral infections (Ozawa et al. 2006 , Knuesel et al. 2014 , Goeden et al. 2016 . Indeed, increased maternal CRP levels were significantly associated with schizophrenia in offspring (OR 1.12, 95% CI 1.02-1.24, p = 0.019) (Canetta et al. J o u r n a l P r e -p r o o f 2014a), and elevated maternal TNF-α and IL-8 levels during pregnancy have also been associated with an increased risk of schizophrenia and other psychotic disorders in offspring (Canetta et al. 2014a) . Considering changes in pro-inflammatory cytokines and factors in pregnant women with COVID-19, schizophrenic and psychotic disorders can be a long-term offspring risk of pregnant women with COVID-19.

Over the past few decades, studies have suggested the association between viral infections in pregnancy and autism spectrum disorders (ASD) in offspring. A large population study in Denmark, evaluating 1,612,342 children born between 1980 and 2005, found an increased risk of ASD in children of mothers with a history of viral infection in the first trimester of pregnancy [adjusted hazard ratio (aHR) 2.98 (CI: 1.29-7.15)] and bacterial infection in the second trimester of pregnancy (aHR 1.42, CI 1.08-1.87). A total of 283 children were exposed to viral infection in the first trimester, and the frequent viral infections exposed to these children were influenza (25%), viral gastroenteritis (20%), and unspecified viral infection (12%) (Atladóttir et al. 2010) . A metaanalysis of 15 studies with more than 40,000 ASD cases also demonstrated an increased risk for ASD after prenatal exposure to infectious diseases (OR 1.13, 95% CI 1.03-1.23) (Jiang et al. 2016) .

In animal models, the role of maternal immune activation (MIA) with an intense inflammatory response has been reported in conditions of behavioral changes in the offspring. In rodent models of MIA, maternal IL-17a promoted abnormal cortical development in offspring and ASD-like behavioral abnormalities in offspring. Treatment with anti-IL-17a blocking antibody in pregnant dams ameliorated MIA-associated behavioral abnormalities (Choi et al. 2016 ). Using the same animal model, the elevated IL-6 level was associated with changes in offspring behavior. 

The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (covid-19): A systematic review and meta-analysis

The fetal origins of mental illness

Birth weight is inversely correlated with blood pressure: Population-based study

Visualization of sars-cov-2 virus invading the human placenta using electron microscopy

Maternal virus infections in pregnancy and type 1 diabetes in their offspring: Systematic review and meta-analysis of observational studies

Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders

Are clinical outcomes worse for pregnant women at ≥20 weeks' gestation infected with coronavirus disease 2019? A multicenter case-control study with propensity score matching

Placental pathology in covid-19 positive mothers: Preliminary findings

Growth and chronic disease: Findings in the Helsinki birth cohort

Detection of sars-cov-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents

Epidemiology of coronavirus disease 2019 in pregnancy: Risk factors and associations with adverse maternal and neonatal outcomes

Serologic evidence of prenatal influenza in the etiology of schizophrenia

Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring

Maternal infections and subsequent psychosis among offspring

Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort

Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring

Covid-19 in pregnant women: A systematic review and meta-analysis

Global, regional, and national estimates of levels of preterm birth in 2014: A systematic review and modelling analysis. The Lancet. Glob Health

Preterm birth in china between 2015 and 2016

The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring

Covid-19 and first trimester spontaneous abortion: A case-control study of 225 pregnant patients

Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data

Coronavirus disease 2019 (covid-19) pandemic and pregnancy

Risk factors associated with adverse fetal outcomes in pregnancies affected by coronavirus disease 2019 (COVID-19): A secondary analysis of the wapm study on covid-19

Understanding angiotensin ii type 1 receptor signaling in vascular pathophysiology

Characteristics of women of reproductive age with laboratory-confirmed sarscov-2 infection by pregnancy status -united states

Immune-inflammatory parameters in covid-19 cases: A systematic review and metaanalysis

The T helper type 17/regulatory T cell paradigm in pregnancy

Sars-cov-2 seroprevalence among parturient women in Philadelphia

Covid-19 in pregnant women: Case series from one large new york city obstetrical practice

Cytokine storm syndrome in coronavirus disease 2019: A narrative review

Angiotensin-converting enzyme 2: Sars-cov-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ace2

The role of infection in miscarriage

Maternal inflammation disrupts fetal neurodevelopment via increased placental output of serotonin to the fetal brain

A sars-cov-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing

A systematic review and meta-analysis of influenza a virus infection during pregnancy associated with an increased risk for stillbirth and low birth weight

Maternal infection in pregnancy and childhood leukemia: A systematic review and meta-analysis

Chronic conditions and health care needs of adolescents born at 23 to 25 weeks' gestation

Sars-cov-2 infection of the placenta

Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A systematic review

Metabolic syndrome mediates pro-inflammatory responses of inflammatory cells in preeclampsia

Maternal infection during pregnancy and risk of autism spectrum disorders: A systematic review and meta-analysis

Virology, epidemiology, pathogenesis, and control of covid-19

Potential influence of covid-19/ace2 on the female reproductive system

The tolerogenic function of regulatory t cells in pregnancy and cancer

Lymphocyte activation in the development of immune tolerance in women with recurrent pregnancy loss

Rehospitalization through childhood and adolescence: Association with neonatal morbidities in infants of very low birth weight

Th17 and regulatory t cells in women with recurrent pregnancy loss

Placental pathology in relation to uterine artery doppler findings in pregnancies with severe intrauterine growth restriction and abnormal umbilical artery doppler changes

Maternal and neonatal outcomes of pregnant women with covid-19 pneumonia: A casecontrol study

Why are pregnant women susceptible to COVID-19? An immunological viewpoint

H1N1 in pregnancy: A tertiary care centre experience

Births: Final data for 2018

Characterization of the inflammatory response to severe covid-19 illness

Influenza virus infection in pregnancy: A review

High rate of chronic villitis in placentas of pregnancies complicated by influenza A/H1N1 infection

Pre-eclampsia-like syndrome induced by severe covid-19: A prospective observational study

The unique immunological and microbial aspects of pregnancy

Neurodevelopmental abnormalities in children with in utero zika virus exposure without congenital zika syndrome

Pleiotropy and specificity: Insights from the interleukin 6 family of cytokines

COVID-19 and Treg/Th17 imbalance: Potential relationship to pregnancy outcomes

Outcomes of infants born to women with influenza A(H1N1)pdm09

The placentas of patients with severe acute respiratory syndrome: A pathophysiological evaluation

Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: A neurodevelopmental animal model of schizophrenia

Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples

Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? ELife

Risks associated with viral infections during pregnancy

Maternal inflammation, growth retardation, and preterm birth: Insights into adult cardiovascular disease

Recurrent intrauterine growth restriction: Characteristic placental histopathological features and association with prenatal vascular doppler

Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in preeclampsia

Prior and novel coronaviruses, COVID-19, and human reproduction: What is known?

Placental pathology in COVID-19

Increased placental macrophages and a pro-inflammatory profile in placentas and maternal serum in infants with a decreased growth rate in the third trimester of pregnancy

COVID-19 illness in native and immunosuppressed states: A clinicaltherapeutic staging proposal

Low birth weight, later renal function, and the roles of adulthood blood pressure, diabetes, and obesity in a British birth cohort

Maternal immune activation alters fetal brain development through interleukin

Maternal and neonatal outcomes associated with covid-19 infection: A systematic review

Third trimester placentas of sars-cov-2-positive women: Histomorphology, including viral immunohistochemistry and in situ hybridization

Paradoxical long-term impact of maternal influenza infection on neonates and infants

Neonatal outcomes of extremely preterm infants from the NICHD neonatal research network

Universal screening for SARS-CoV-2 in women admitted for delivery

The tragedy of COVID-19 in brazil: 124 maternal deaths and counting

Pregnancy and COVID-19: A systematic review of maternal, obstetric and neonatal outcomes

Convergence of placenta biology and genetic risk for schizophrenia

Cytokine storm and leukocyte changes in mild versus severe sars-cov-2 infection: Review of 3939 COVID-19 patients in china and emerging pathogenesis and therapy concepts

Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome

Who coronavirus disease (COVID-19) dashboard

ICD-10 : International statistical classification of diseases and related health problems : Tenth revision

An update on current therapeutic drugs treating covid-19

The outbreak of covid-19: An overview

Pathological findings of covid-19 associated with acute respiratory distress syndrome

Maternal infection during pregnancy and type 1 diabetes mellitus in offspring: A systematic review and meta-analysis

Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: Adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model